RECRUITING Not applicable ClinicalTrials.gov

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis

Sponsor: E-DA Hospital • ClinicalTrials.gov ID: NCT03812016

Registry updated: 2026-09-23

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with blepharoptosis.

Interventions

Feedback-enabled magnetic device (Device)
The device comprises 1 or 2 matched pairs of one near-infrared light-emitting diode and one sensor, a magnetic actuator, an iron sheet, and a biosignal acquisition module. The efficacy and safety were assessed using the feedback-enabled magnetic device.

Eligibility criteria

Inclusion Criteria: * Patients with ptosis; they are capable of understanding and complying with protocol requirements * Aged 18 years old or older Exclusion Criteria: * Upper eyelid scar, contracture, or fibrosis due to previous surgical intervention(s) * Patients with psychiatric (or mental) disorders; they are unable to cooperate or follow the study procedure * Children younger than 18 years of age

Conditions

Blepharoptosis Device Usability

Locations

E-Da Hospital — Kaohsiung City, Taiwan
Shin Kong Wu Ho-Su Memorial Hospital — Taipei, Taiwan

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment